Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial (Q35603530)
Jump to navigation
Jump to search
scientific article published on 16 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial |
scientific article published on 16 February 2015 |
Statements
1 reference
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial (English)
1 reference
Christopher P Cannon
1 reference
Bertrand Cariou
1 reference
James M McKenney
1 reference
Christelle Lorenzato
1 reference
Robert Pordy
1 reference
Umesh Chaudhari
1 reference
ODYSSEY COMBO II Investigators
1 reference
16 February 2015
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference